SCHEMBL4757484

SCHEMBL4757484

CC(=O)Oc1c(Br)cc(Br)cc1C(=O)Nc1nc(NS(C)(=O)=O)cs1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SORT1 Q99523 1/20 0.40
PDE5A O76074 2/20 0.37
USP2 O75604 1/20 0.35
USP8 P40818 1/20 0.35
NPC1 O15118 5/20 0.34
RAB9A P51151 5/20 0.34
KDM4E B2RXH2 2/20 0.34
HTT P42858 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 2/20 0.34
ALDH1A1 P00352 3/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HPGD P15428 2/20 0.33
MAPK1 P28482 1/20 0.33
RECQL P46063 1/20 0.33
PDE1A P54750 1/20 0.33
PDE1B Q01064 1/20 0.33
PDE1C Q14123 1/20 0.33
GAA P10253 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757488 0.86 SLC2A1 (0.41) SORT1PDE5AUSP2USP8NPC1
SCHEMBL4940584 0.79 SORT1 (0.36) SORT1PDE5AUSP2USP8NPC1
SCHEMBL4757512 0.78 NPC1 (0.40) NPC1RAB9AKDM4EHTTSMN1; SMN2
SCHEMBL4757398 0.78 SORT1 (0.51) SORT1USP2USP8NPC1RAB9A
SCHEMBL4756815 0.75 PDE5A (0.41) SORT1PDE5AHTTSMN1; SMN2ALDH1A1
SCHEMBL10114458 0.71 SORT1 (0.41) SORT1PDE5AUSP2USP8NPC1
SCHEMBL16918845 0.71 SORT1 (0.36) SORT1PDE5AUSP2USP8NPC1
SCHEMBL4757394 0.70 NPC1 (0.64) NPC1RAB9AKDM4EHTTSMN1; SMN2
SCHEMBL4756728 0.68 MEN1 (0.47) SORT1NPC1RAB9AKDM4EHTT
SCHEMBL4318333 0.68 HSD17B10 (0.69) USP2KDM4EHSD17B10ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC SORT1 4431/4885PDE5A 4694/4885USP2 3480/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC SORT1 4431/4885PDE5A 4694/4885USP2 3480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.